MedPath

A study to investigate a blood test (Arterial lactate) to predict complications (DCI/Vasospasm) and poor prognosis in patient with aneurysmal SAH.

Not Applicable
Conditions
Health Condition 1: I609- Nontraumatic subarachnoid hemorrhage, unspecified
Registration Number
CTRI/2022/09/045806
Lead Sponsor
SCTIMST
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Consenting Adult patients (Caregivers in-case of incapacitated patients) with aSAH admitted at SCTIMST

-Age group 18 years and above (with both sexes included)

-Anterior Circulation Bled Aneurysms

Exclusion Criteria

-Patients/caregivers not consenting for participation in the study.

-Patients with history of Heart Failure/Renal failure/Liver Failure/Shock/Alcoholism/Malignancy -Patients with known congenital errors of Metabolism -Patients on antiretrovirals (NRTI)/Metformin/ Salicylates/beta-adrenergic agonists

-Pregnant/Nursing mothers

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study serial arterial blood lactate levels in patients presenting with aSAH and check for any correlation between its levels and time to onset of DCI and incidence of DCI.Timepoint: Time to occurrence of Vasospasm or DCI
Secondary Outcome Measures
NameTimeMethod
To check for any correlation between arterial lactate levels and other outcome parameters.Timepoint: Time to discharge from Hospital
© Copyright 2025. All Rights Reserved by MedPath